BMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125

Benzinga · 3d ago
BMO Capital analyst Sean Dodge maintains HealthEquity (NASDAQ:HQY) with a Outperform and raises the price target from $105 to $125.